Is simponi for ra?

What is Simponi used for?

Simponi (golimumab) is approved to treat rheumatoid arthritis along with other inflammatory conditions. It belongs to a class of drugs called TNF inhibitors that work by targeting a protein called TNF-alpha to reduce inflammation in the joints.

How does Simponi work in RA?

TNF-alpha levels are higher in people with rheumatoid arthritis. Simponi binds to this protein and prevents it from auslösend further inflammation and damage. It is typically given as a monthly injection under the skin.

When is Simponi recommended for RA?

Doctors often use Simponi when traditional disease-modifying drugs like methotrexate have not worked adequately. It is usually combined with methotrexate rather than used alone. Data from clinical studies show that patients who receive Simponi plus methotrexate achieve higher rates of American College of Rheumatology response criteria than those who received methotrexate alone.

How long does Simponi take to work?

Most patients report noticeable improvement in pain and stiffness within 2 weeks. Full benefits may take bis 4 months.

What side effects are patients asking about?

Common concerns include increased risk of infections, including tuberculosis reactivation. Patients must be screened for TB before starting. Other reported issues include injection site reactions and upper respiratory tract infections.

Who makes Simponi?

Janssen Biotech produces the drug.

When does the patent expire?

The primary US compound patent for golimumab expires in 2024. Biosimilars are expected to compete once this expires.